Skip to Navigation | Skip to Main Content | Skip to Site Map

MyFloridaHouse.gov | Mobile Site

Senate Tracker: Sign Up | Login

The Florida Senate

CS/HB 675: Pharmacies

GENERAL BILL by Health and Human Services Committee ; Brodeur

Pharmacies; Revises membership of Board of Pharmacy; establishes Class III institutional pharmacies; provides requirements for such pharmacies; revises notice requirements; authorizes distribution of medicinal drugs & prepackaged drug products without specified permit under certain conditions; removes provision exempting certain drug repackagers from specified permit requirements.

Effective Date: 7/1/2018
Last Action: 3/27/2018 - Chapter No. 2018-95
Bill Text: PDF

Expand All Collapse All

  • Bill History

    Date Chamber Action
    11/14/2017 House • Filed
    11/27/2017 House • Referred to Health Quality Subcommittee; Appropriations Committee; Health and Human Services Committee -HJ 61
    1/9/2018 House • Introduced -HJ 60
    1/11/2018 House • On Committee agenda-- Health Quality Subcommittee, 01/16/18, 11:30 am, Mashburn Hall
    1/16/2018 House • Favorable by Health Quality Subcommittee; YEAS 14 NAYS 0 -HJ 353
    1/17/2018 House • Now in Appropriations Committee -HJ 353
    2/12/2018 House • On Committee agenda-- Appropriations Committee, 02/14/18, 9:00 am, Webster Hall
    2/14/2018 House • Favorable by Appropriations Committee; YEAS 25 NAYS 0 -HJ 595
    • Now in Health and Human Services Committee -HJ 595
    2/19/2018 House • On Committee agenda-- Health and Human Services Committee, 02/21/18, 9:00 am, Morris Hall
    2/21/2018 House • CS by- Health and Human Services Committee; YEAS 15 NAYS 0 -HJ 671
    2/22/2018 House • Pending review of CS -under Rule 7.18(c)
    • Placed on Calendar -HJ 669
    • Placed on Special Order Calendar, 02/28/18
    • CS by Health and Human Services Committee read 1st time -HJ 664
    2/28/2018 House • Read 2nd time -HJ 715
    • Placed on 3rd reading
    3/1/2018 House • Read 3rd time -HJ 750
    • CS passed; YEAS 113 NAYS 0 -HJ 750
    3/1/2018 Senate • In Messages
    • Referred to Health Policy; Regulated Industries; Rules -SJ 441
    • Received -SJ 441
    3/8/2018 Senate • Withdrawn from Health Policy; Regulated Industries; Rules -SJ 910
    • Placed on Calendar, on 2nd reading -SJ 910
    • Substituted for CS/SB 1128 -SJ 910
    • Read 2nd time -SJ 910
    • Placed on 3rd reading
    3/9/2018 Senate • Read 3rd time -SJ 1014
    • CS passed; YEAS 38 NAYS 0 -SJ 1014
    3/9/2018 House • Ordered enrolled -HJ 1210
    3/21/2018 • Signed by Officers and presented to Governor
    3/23/2018 • Approved by Governor
    3/27/2018 • Chapter No. 2018-95

    Top of SectionTop of Page

  • CS/HB 675, Enrolled (Current Bill Version) Posted 3/9/2018 at 6:50 PM

    Bill Text:   PDF
    Analyses:   None

    Related Bills (1)

    Bill Number Subject Filed By Relationship Last Action and Location Track Bills
    S 1128 (c1) Pharmacies Stargel Similar Last Action: 3/8/2018 S Laid on Table, companion bill(s) passed, see CS/HB 675 (Ch. 2018-95) -SJ 910

    Citations - Statutes (6)

    Citation Catchline Location in Bill Location In Bill Help
    465.003 Definitions. Page 1 (pdf)
    465.004 Board of Pharmacy. Page 3 (pdf)
    465.019 Institutional pharmacies; permits. Page 4 (pdf)
    465.0252 Substitution of interchangeable biosimilar products. Page 7 (pdf)
    499.003 Definitions of terms used in this part. Page 8 (pdf)
    499.01 Permits. Page 9 (pdf)

    Top of SectionTop of Page

  • CS/HB 675, Committee Substitute 1 Posted 2/22/2018 at 10:37 AM

    Bill Text:   PDF
    Analyses:   None

    Related Bills (1)

    Bill Number Subject Filed By Relationship Last Action and Location Track Bills
    S 1128 (c1) Pharmacies Stargel Similar Last Action: 3/8/2018 S Laid on Table, companion bill(s) passed, see CS/HB 675 (Ch. 2018-95) -SJ 910

    Floor Votes (2)

    Date Chamber Result
    3/1/2018 1:38 PM House 113 Yeas - 0 Nays
    3/9/2018 6:12 PM Senate 38 Yeas - 0 Nays

    Citations - Statutes (6)

    Citation Catchline Location in Bill Location In Bill Help
    465.003 Definitions. Page 1 (pdf)
    465.004 Board of Pharmacy. Page 3 (pdf)
    465.019 Institutional pharmacies; permits. Page 4 (pdf)
    465.0252 Substitution of interchangeable biosimilar products. Page 7 (pdf)
    499.003 Definitions of terms used in this part. Page 8 (pdf)
    499.01 Permits. Page 9 (pdf)

    Top of SectionTop of Page

  • HB 675, Original Filed Version Posted 11/14/2017 at 2:57 PM

    Bill Text:   PDF
    Analyses:   Health Quality Subcommittee (Post-Meeting) 3/27/2018 (pdf)
    Appropriations Committee (Post-Meeting) 2/14/2018 (pdf)
    Health and Human Services Committee (Post-Meeting) 2/22/2018 (pdf)

    Related Bills (1)

    Bill Number Subject Filed By Relationship Last Action and Location Track Bills
    S 1128 (c1) Pharmacies Stargel Identical Last Action: 3/8/2018 S Laid on Table, companion bill(s) passed, see CS/HB 675 (Ch. 2018-95) -SJ 910

    Committee Amendments (1)

    Amendment Sponsor Filed Last Committee Action Format
    128723 - Amendment
    Remove line 218 and insert:
    Brodeur 2/20/2018
    7:24 PM
    Adopted without Objection
    2/22/2018
    PDF

    Citations - Statutes (6)

    Citation Catchline Location in Bill Location In Bill Help
    465.003 Definitions. Page 1 (pdf)
    465.004 Board of Pharmacy. Page 3 (pdf)
    465.019 Institutional pharmacies; permits. Page 4 (pdf)
    465.0252 Substitution of interchangeable biosimilar products. Page 7 (pdf)
    499.003 Definitions of terms used in this part. Page 8 (pdf)
    499.01 Permits. Page 9 (pdf)

    Top of SectionTop of Page